MedPath

Incidence of postoperative residual curarization in the post-anaesthesia recovery unit

Not Applicable
Recruiting
Conditions
Postoperative residual curarization
Anaesthesiology - Anaesthetics
Registration Number
ACTRN12613001357741
Lead Sponsor
Dr Wendy H.L.Teoh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
250
Inclusion Criteria

ASA I-III patients who underwent a general anaesthetic for major gynaecological, breast , reconstructive or aesthetic surgery, in whom a neuromuscular blocking drug was administered.

Exclusion Criteria

< 21 years, had underlying neuromuscular disease, use of medication known to interfere with neuromuscular transmission.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Our primary outcome variable was the incidence of PORC in awake extubated patients 10 min post-PACU arrival. ( A TOF ratio <0.9 was used as criteria for defining postoperative residual weakness.)[Within 10min of PACU arrival for each participant]
Secondary Outcome Measures
NameTimeMethod
PACU side effects (symptoms of nausea as reported by participants, and actual witnessed episodes of vomiting by PACU staff)[Monitored throughout duration of each participant's PACU stay.];Time to PACU discharge readiness [time deemed medically appropriate for patients to leave the PACU];Actual PACU length of stay [Time from arrival to actual departure from the PACU.];Adverse respiratory events (upper airway obstruction requiring intervention, bronchospasm, aspiration of gastric or oropharyngeal contents, episodes of oxygen saturation below 93%, hypoxemia requiring supplemental oxygen, need for tracheal reintubation). These outcomes are observed and/or reported by PACU nurses. [Monitored throughout duration of each participant's PACU stay ]
© Copyright 2025. All Rights Reserved by MedPath